Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

NYMX $4.45 2.0200 +83.13%
MNTA $13.36 1.3600 +11.33%
BLRX $0.96 0.0970 +11.27%
TGTX $6.79 0.5700 +9.16%
STML $8.00 0.3100 +4.03%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARWR $6.89 -1.1900 -14.73%
SPHS $3.38 -0.5100 -13.11%
THLD $0.86 -0.1139 -11.74%
BDSI $2.51 -0.3300 -11.62%
XBIT $14.14 -1.4600 -9.36%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Next > | Last >>

BioLineRx Signs Second Clinical Immuno-Oncology Collaboration Agreement to Investigate Combination of BL-8040 and KEYTRUDA® for Pancreatic Cancer

(Yahoo! Finance) Aug 8, 2016 - BioLineRx Ltd. announced today the signing of a collaboration agreement with The University of Texas MD Anderson Cancer Center for the investigation of BL-8040 in combination with KEYTRUDA® (pembrolizumab) in pancreatic cancer.
read article 

New Drug Class Gives Hope For Better Treatments For Incurable Myeloma

(Walter and Eliza Hall Institute [Australia]) Aug 8, 2016 - Australian researchers have discovered that a new class of anti-cancer agents may be effective in treating multiple myeloma, an incurable bone marrow cancer.
read article 

Melanoma Less Common But More Deadly For Black Patients

(FoxNews/Reuters) Aug 4, 2016 - Even though Caucasians are much more likely to develop skin cancer than other ethnic groups, people of color who do get the disease are less likely to survive, a U.S. study suggests.
read article 

Ovarian Cancer Risk Linked To Socioeconomic Status In African-American Women

(MUSC) Aug 5, 2016 - Higher socioeconomic status is associated with lower ovarian cancer risk in African-American women, according to a new study led by investigators at the Medical University of South Carolina. It was published online August 3 in the American Journal of Epidemiology.
read article 

High-dose Radiation Therapy As Effective As Surgery For Aggressive Prostate Cancer

(UCLA Research Alert) Aug 5, 2016 - A study by researchers at the UCLA Jonsson Comprehensive Cancer Center provides convincing evidence that radiation-based treatments and surgery are equally effective treatments for aggressive prostate cancer.
read article 

Hormone Therapy For Prostate Cancer May Pose A Risk For Black Men

(Washington Post/To Your Health) Aug 5, 2016 - Black men treated with hormone therapy for prostate cancer may have a higher risk of death than white men undergoing the same therapy, according to a new study. But the deaths aren’t actually caused by prostate cancer.
read article (free registration required) 

Little Useful Info From NSCLC Trial

(MedPage Today) Aug 4, 2016 - A trial of biomarker-driven treatment for patients with non-small cell lung cancer (NSCLC) achieved mixed results, providing additional support for biomarker-driven strategies but failing to identify a clearly superior biomarker-based treatment strategy.
read article (free registration required) 

Large Population-Based Studies Bolster Evidence that Insurance Status Affects Cancer Patients’ Health and Survival

(Wiley) Aug 8, 2016 - Two new studies indicate that health insurance status may impact patients’ health outcomes following a diagnosis of cancer.
read press release 

FDA Approves Pembrolizumab for Head and Neck Squamous Cell Carcinoma

(ASCO in Action) Aug 5, 2016 - On August 5, 2016, the U. S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA® injection, Merck Sharp & Dohme Corp.) for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy.
read article 

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy

(Merck) Aug 8, 2016 - Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy, at a fixed dose of 200 mg every three weeks, for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy.
read corporate press release 

Uninsured And Medicaid Cancer Patients Receive Worse Treatment, Die Sooner

(Medical Daily) Aug 8, 2016 - A pair of new studies published in the journal Cancer reaffirm previous findings that the income and wealth gap often leads to a cancer treatment gap.
read article 

U.S. Panel Backs Approval of Egalet's Abuse-Resistant Painkiller

(Reuters) Aug 4, 2016 - A U.S. advisory panel on Thursday recommended approval of Egalet Corp's long-acting opioid painkiller, Arymo ER, saying it dulls pain and could deter abuse by addicts seeking a quick high.
read article 

Huge Data Breach at Health System Leads to Biggest Ever Settlement

(CNBC) Aug 5, 2016 - One of the nation's biggest health-care systems has agreed to pay the largest settlement ever by a single entity for potential violations of federal patient privacy law, related to breaches that compromised the electronic data of 4 million patients.
read article 

Are You Just a Number? How New Healthcare Value Frameworks Miss the Point

(Forbes) Aug 4, 2016 - Historically, physicians and patients work together to make treatment decisions. Physicians leverage their clinical expertise to diagnose the problem and offer patients a menu of treatment options. Patients share personal information about their bodies, hopes, fears, and much more in order to help with diagnosis and finding a treatment that matches their own preferences.
read article 

High Prices Make Once-Neglected 'Orphan' Drugs a Booming Business

(Washington Post) Aug 4, 2016 - Three decades ago, Congress listened to the plight of Americans sick with diseases so rare many people had never heard of them. They were victims of a pharmaceutical market failure — “orphans” ignored by drug companies because, the thinking went, tiny groups of patients would lead to trifling sales.
read article (free registration required) 

CMS Releases FAQs On Transparency And Quality Rating Guidelines

(Health Affairs Blog) Aug 4, 2016 - On August 3, CMS released at its website (registration required), a series of frequently asked questions (FAQs), most of which provide additional detail on the transparency and quality rating guidelines released on July 25, 2016. The FAQs clarify that only qualified health plan insurers in consumer display pilot states (Michigan, Ohio, Oregon, Pennsylvania, Virginia, and Wisconsin) and in states with state-based marketplaces that display star ratings can use their star ratings in marketing materials.
read article 

NYU Lutheran Surgeon Returns to His Roots – Helping to Treat Colon and Rectal Cancer in Brooklyn

(NYU Lutheran) Aug 4, 2016 - Brooklyn has always been home to Josef A. Shehebar, MD, FACS, FASCRS. When he was recruited recently by NYU Lutheran to expand and grow the Division of Colon and Rectal Surgery, Dr. Shehebar couldn't pass up the opportunity to work in the borough where his roots are firmly planted.
read press release 

HCA Midwest Picks KC-Area Leader for Sarah Cannon Cancer Institute

(Kansas City Business Journal) Aug 4, 2016 - Ryan Hallenbeck will lead the efforts of Sarah Cannon Cancer Institute throughout the HCA Midwest Health system.
read article 

Facing Bleak Odds, Cancer Patients Chase One Last Chance — in Cuba

(STAT) Aug 5, 2016 - Mick Phillips didn’t think much about it when he started coughing a lot in the fall of 2009. He’d been doing a lot of yard work at his home in Appleton, Wisc., and thought he might be reacting to leaf mold. In fact, he had stage 3 lung cancer.
read article 

German Chemotherapy Firm Zytoservice Attracts Bids From Buyout Funds - Sources

(Reuters) Aug 4, 2016 - German chemotherapy compound maker Zytoservice has attracted offers in a second bidding round from several buyout groups, people familiar with the situation said.
read article 

Vyriad Signs Exclusive License Agreement for STING Technology for Development of Enhanced Oncolytic Virotherapy Treatments

(Yahoo! Finance) Aug 5, 2016 - Vyriad today announced an exclusive global license agreement with StingInn, LLC for StingInn's STING oncolytic virus technology for use in Vyriad's oncolytic virotherapy product candidates for the treatment of advanced-stage cancers.
read article 

Stanford Launches New Program for Rare Slow-Growing Cancers

(Stanford Medicine/Scope blog) Aug 4, 2016 - Cancer. It’s a single — and terrifying — term for a wide array of related diseases. Cancers’ differences in location, genetic makeup and response to treatment can be wildly dissimilar, but all tend to feature rapidly proliferating mutant cells that expand into surrounding tissue.
read article 

Juno Licenses BCMA From MSK, Eureka Therapeutics

(GEN) Aug 5, 2016 - Juno Therapeutics has licensed rights from Memorial Sloan Kettering Cancer Center (MSK) and Eureka Therapeutics for a novel, fully human binding domain targeting B-cell maturation antigen (BCMA), along with binding domains against two additional undisclosed multiple myeloma targets.
read article 

Smog May Shorten Lives of Lung Cancer Patients

(U.S. News & World Report/HealthDay News) Aug 5, 2016 - Air pollution may shorten the lives of lung cancer patients, a new study suggests.
read article 

Procedure Providing Hope for Some Brain Cancer Patients

(Mississipi Business Journal) Aug 4, 2016 - Tiny electrical fields that help your cells communicate are being harvested at the University of Mississippi Medical Center to fight a type of brain cancer that primarily strikes adults.
read article